We first assessed the expression levels of FPR1 and FPR2 mRNA in four GC cell lines, i.e., HGC27, derived from human gastric carcinoma, KATOIII, AGS, and NCl–N87, derived from human gastric adenocarcinoma. The gene discussed is FPR1; the disease is gastric adenocarcinoma.